The combination of ruxolitinib and Bcl-2/Mcl-1 inhibitors has a synergistic effect on leukemic cells carrying a SPAG9::JAK2 fusion
Available in National Diet Library
Find on the publisher's website
国立国会図書館デジタルコレクション
Digital data available
Check on the publisher's website
DOI[10.1038/s41417-022-00511-z]to the data of the same series
Search by Bookstore
Read this material in an accessible format.
Search by Bookstore
Read in Disability Resources
- Other Services
Bibliographic Record
You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.
- Material Type
- 博士論文
- Author/Editor
- 眞弓, あずさ
- Publication, Distribution, etc.
- Publication Date
- 2022
- Publication Date (W3CDTF)
- 2022
- Alternative Title
- ルキソリチニブとBcl-2阻害剤/Mcl-1阻害剤の併用はSPAG9-JAK2融合遺伝子を有する白血病細胞に対して相乗効果を示す
- Degree grantor/type
- 京都府立医科大学
- Date Granted
- 2022-10-14
- Date Granted (W3CDTF)
- 2022-10-14